Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
Parkinson
58%
Luxembourg
46%
Levodopa-induced Dyskinesia
35%
Idiopathic Parkinson's Disease
35%
Polygenic Risk Score
22%
SARS-CoV-2 Infection
21%
COVID-19
21%
Clinical Data
19%
Luxembourgish
19%
GBA1
19%
Pembrolizumab
17%
Disease Effects
17%
Coronavirus Disease (COVID)
17%
Householder
17%
Prospective Longitudinal Cohort
17%
Cardiovascular History
17%
Prognostic Analysis
17%
Risk Variant
17%
Dietary Model
17%
Disease Duration
17%
Dopaminergic Pathway
17%
Long-read Sequencing
17%
Acknowledgment
17%
Impulse Control Disorders
17%
Oxygen Control
17%
SpO2
17%
Randomized Crossover Trial
17%
Disease Severity
17%
Cross-cohort
17%
Authorship Criteria
17%
HPV Carcinogenesis
17%
Outcome Prediction
17%
Gait Data
17%
Metabolomics Data
17%
Vorinostat
17%
Circulating Tumor DNA (ctDNA)
17%
Tilia
17%
Linden
17%
Mild Cognitive Impairment
17%
Preanalytical Variables
17%
Allergy Epidemic
17%
Memory Impairment
17%
Open-source Tools
17%
Health Effects
17%
Healthy Adults
17%
External Quality Assurance
17%
Social Determinants of Mental Health
17%
Preterm Infants
17%
Processing Methods
17%
Carrot
17%
Post-COVID
17%
Risk Factors
17%
Whey Protein Isolate
17%
Soy Protein Isolate
17%
Metabolic Health
17%
Pollutant Mixture
17%
Machine Learning
17%
Immunomodulatory Potential
17%
Gut Microbial Function
17%
European Health Examination Survey
17%
Aging Effect
17%
Polygenic Background
17%
Cardiovascular Risk
17%
Xanthine Metabolism
17%
Predictors of Cognitive Impairment
17%
Personalized Medicine
17%
Idiopathic PD
17%
Gut Microbiota
17%
Pollen Allergy
17%
Variant Carriers
17%
Major Risk
17%
Tomato Juice
17%
Age of Onset
17%
Carotenoid Bioavailability
17%
Translational Medicine
17%
Cross-sectional Observational Study
17%
Quality Assessment
17%
Multi-omics
17%
Clinical Phenotype
17%
Metabolic Syndrome
17%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
17%
Chemical Contaminants
17%
Hypertriglyceridemia
17%
DNA Methylation (DNAm)
17%
Population-based Cohort
17%
Post SARS-CoV-2
17%
Epigenetic Modification
17%
Methylation Landscape
17%
Human Papillomavirus
16%
Manual Control
14%
Fibrosis-4 Index
14%
FiO2
14%
DNA Extraction
14%
High Blood Pressure
14%
Hyperglycemia
14%
2-dimensional Shear Wave Elastography
12%
Tmax
11%
Triacylglycerol
11%
Metabolic Dysfunction-associated Steatohepatitis
11%
Medicine and Dentistry
Parkinson's Disease
89%
Nonalcoholic Fatty Liver
53%
Meta-Analysis
53%
Fibrosis
44%
Gait
40%
Diagnostic Accuracy
38%
COVID-19
35%
Metabolomics
35%
Biological Marker
28%
Diseases
26%
Medical Examination
23%
Infection
22%
Education
21%
Systematic Review
20%
Histology
19%
Public Health
19%
Transient Elastography
18%
Gut Microbiome
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Cohort Effect
17%
Cord Blood
17%
Disease Severity
17%
Immunoglobulin
17%
Mild Cognitive Impairment
17%
Hypoxic-Ischemic Encephalopathy
17%
Pulse Rate
17%
Observational Study
17%
Shear Wave Elastography
17%
Elastography
17%
Magnetic Resonance Imaging
17%
Patient-Data
17%
Tamsulosin
17%
Multi-Omics
17%
Translational Medicine
17%
Personalized Medicine
17%
Metabolic Syndrome
17%
Dopamine
17%
Levodopa-Induced Dyskinesia
17%
Cardiovascular System
17%
Chemical Pollutant
17%
Hypertriglyceridemia
17%
Comorbidity
15%
Hypertension
14%
Hyperglycemia
14%
Area under the Curve
13%
Magnetic Resonance Elastography
12%
Prevalence
10%
Abdominal Obesity
10%
Cardiovascular Disease
10%
Liver Biopsy
9%
Birth Weight
8%
Fraction of Inspired Oxygen
8%
Assisted Ventilation
8%
Neonatal Intensive Care Unit
8%
Gestational Age
8%
Stereotypic Movement Disorder
8%
Liver Cirrhosis
8%
Unified Parkinson's Disease Rating Scale
8%
Levodopa
7%
Psychological Well-Being
7%
Herbicide
7%
Fungicide
7%
Cross-Validation
6%
Cohort Analysis
6%
Edetic Acid
5%
Biomarker Study
5%
Health Outcomes
5%
Genetics
5%
Liver Fibrosis
5%
Myelodysplastic Syndrome
5%
Dysautonomia
5%
Immunology and Microbiology
Infection
62%
Infectious Disease
62%
Gut Microbiome
58%
Severe Acute Respiratory Syndrome Coronavirus 2
56%
COVID-19
55%
Squamous Cell
35%
Parkinson's Disease
35%
Cardiovascular System
35%
Metagenomics
31%
Taxon
27%
Prevalence
26%
Metabolite
23%
Pembrolizumab
21%
Wart Virus
21%
Gastrointestinal Tract
20%
Multi-Omics
20%
Methylation
20%
Interleukin 18
17%
Intestine Flora
17%
Hypothalamus
17%
Glucocorticoid
17%
Promoter Region
17%
Immunotherapy
17%
Tumor Necrosis Factor Alpha
17%
Pollen Allergy
17%
Colorectal Carcinoma
17%
DNA Methylation
17%
Microbiome
16%
Blood Plasma
14%
Immune Response
9%
Pharmacodynamics
9%
Alphaproteobacteria
8%
Clostridiales
8%
Mollicutes
8%
Blood Pressure
8%
Lineages
8%
Diabetes Mellitus Type 1
8%
Microflora
8%
Immunocompetent Cell
8%
Immune System
8%
Pollen
8%
Biosynthesis
8%
Overall Survival
7%
Psychological Well-Being
7%
Immune Checkpoint Inhibitor
7%
Transcriptomics
5%
Serology
5%